Case report: Abscesses in children caused by invasive group A Streptococcus
Danchun Guo, Shuting Zhuang, Qinghua Lu, Yunsheng Chen, Qing Meng, Lifang Sun, Yuejie Zheng, Wenjian Wang, Dingle Yu

TL;DR
This case report describes 14 children with abscesses caused by invasive group A Streptococcus and highlights the importance of early diagnosis and treatment.
Contribution
The study provides clinical insights into rare iGAS-induced abscesses in children and treatment recommendations.
Findings
14 pediatric patients with iGAS abscesses were identified, primarily in the lower limbs.
All patients showed improvement with drainage and antibiotics, with no long-term organ damage observed.
β-lactam antibiotics were effective, with vancomycin used in some cases with poor outcomes.
Abstract
Streptococcus is one of the common pathogens of suppurative infections. Invasive group A Streptococcus (iGAS) infections often develop from skin or soft tissue infections, and streptococcal toxic shock syndrome is considered the main cause of death in Chinese children with iGAS infectious disease. However, soft tissue infections caused by iGAS infections, especially the formation of abscesses, are relatively rare. A retrospective study was conducted, and pediatric in-patients who were diagnosed with an iGAS infection identified by cultures from normally sterile sites and treated in a tertiary hospital during 2016–2018 were included. A total of 14 patients were identified, which included 10 boys and four girls. The patients had an age range from 3 months to 10 years and were diagnosed with soft tissue infections and a formation of abscesses caused by iGAS infections. The most common…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 3 m | Left foot | 2 | 22.38 | 60.9 | 26.5 | 10 | 0.92 | Pus culture GAS | 1.0 | AS 2 d + ACP 6 d |
| 2 | F | 9 m | Right thigh | 6 | 12.97 | 49.1 | 8.3 | 66 | 0.71 | Pus culture GAS | 75.0 | AS 6 d |
| 3 | M | 10 m | Left elbow, right hand | 18 | 32.04 | 64.9 | 37.3 | 46 | 0.73 | Pus culture GAS | 6.4 | AS 18 d |
| 4 | M | 1 y | Left axilla | 3 | 19.40 | - | - | - | - | Pus culture GAS | 12.19 | CS 3 d |
| 5 | M | 1 y 5 m | Left region of the neck | 5 | 30.80 | 64.8 | 24.3 | - | - | Pus culture GAS | 12.0 | AS 4 d |
| 6 | M | 1 y 5 m | Right ankle | 8 | 12.35 | 31.0 | < 0.5 | 41 | 0.22 | Pus culture GAS | 2.0 | AS 8 d |
| 7 | F | 1 y 8 m | Floor of mouth | 3 | 20.07 | 67.5 | 118.9 | - | - | Pus culture GAS | 12.66 | Cefuroxime 3 d |
| 8 | F | 1 y 9 m | Right lower leg | 12 | 34.79 | 80.3 | 4.5 | 39 | 0.01 | Pus culture GAS | 4.0 | Van+CS 11 d |
| 9 | M | 2 y 9 m | Left hip | 3 | 20.78 | 63.3 | 4.1 | 30 | 0.08 | Pus culture GAS | 28.0 | Cefuroxime 3 d |
| 10 | M | 3 y 7 m | Right knee | 4 | 9.09 | 59.7 | 15.3 | 51 | - | Pus culture GAS | 12.0 | CS 4 d |
| 11 | M | 5 y 10 m | Right index finger | 8 | 21.38 | 84.6 | 22.3 | 57 | - | Pus culture GAS | 6.4 | AS 8 d |
| 12 | F | 8 y 1 m | Left upper limb | 11 | 26.70 | 88.3 | 126 | 68 | 0.88 | Pus culture GAS | 1.9 | Cefatriaxone 1 d, Cefatriaxone+Van 6 d, Van 2 d, Cefuroxime 2 d |
| 13 | M | 9 y | Left lower leg | 6 | 7.99 | 47.3 | 2.7 | 25 | - | Pus culture GAS | 1.0 | AS 6 d |
| 14 | M | 10 y 8 m | Osteomyelitis of right proximal tibia and osteomyelitis of left knee | 14 | 46.82 | 89.1 | < 0.5 | 89 | < 0.5 | Pus culture GAS | 12.8 | AS 14 d |
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
| Penicillin | 0 | 0 | 100 (14) | S ≤ 0.125 | 0.004 | 0.008 | 0.004–0.008 |
| Azithromycin | 78.6 (11) | 0 | 21.4 (3) | S ≤ 0.5 R ≥ 2 | >256 | >256 | 0.06–512 |
| Erythromycin | 78.6 (11) | 0 | 21.4 (3) | S ≤ 0.25 R ≥ 1 | >256 | >256 | 0.125–512 |
| Clarithromycin | 78.6 (11) | 0 | 21.4 (3) | S ≤ 0.25 R ≥ 1 | >256 | >256 | 0.06–512 |
| Clindamycin | 78.6 (11) | 0 | 21.4 (3) | S ≤ 0.25 R ≥ 1 | 128 | 256 | 0.015–512 |
| Tetracycline | 78.6 (11) | 0 | 21.4 (3) | S ≤ 2 R ≥ 8 | 64 | 64 | 0.5–64 |
| Levofloxacin | 0 | 0 | 100 (14) | S ≤ 2 R ≥ 8 | 1 | 2 | 0.25–2 |
| Chloramphenicol | 0 | 0 | 100 (14) | S ≤ 4 R ≥ 16 | 2 | 4 | 2–4 |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStreptococcal Infections and Treatments · Neonatal and Maternal Infections · Otolaryngology and Infectious Diseases
Introduction
Streptococcus pyogenes, also known as group A Streptococcus (GAS), is a pathogen with humans as the main host. GAS is widespread throughout the world and is associated with a wide range of diseases of varying severity, including non-invasive diseases, such as pharyngotonsillitis and impetigo, severe invasive infections, such as septicemia, necrotizing fasciitis, and toxic shock syndrome, and immune-related diseases, such as rheumatic fever and glomerulonephritis (1–3). Streptococcus is one of the common pathogens of suppurative infections. Invasive GAS (iGAS) infections often develop from skin or soft tissue infections, and streptococcal toxic shock syndrome (STSS) is the leading cause of death among children with iGAS infectious disease (4). On the one hand, the increase in scarlet fever and iGAS infections in the UK and other European countries in 2022 has caused worldwide concern (2, 3, 5, 6). On the other hand, abscesses caused by iGAS are rarely reported. This retrospective study analyzed the clinical data of children with abscesses caused by iGAS infections in Shenzhen Children's Hospital to explore the clinical characteristics, laboratory results, treatment, and outcomes.
Case description
Setting and patients
This was a retrospective study that included 14 patients with GAS cultured from pus punctured from abscesses. From May 2016 to August 2018, 14 patients with iGAS infections were diagnosed through pus culture with a clinical diagnosis of soft tissue infections with abscess formation. The demographics, clinical presentation, treatment, and microbiological data of patients were collected from electronic medical records.
Bacterial identification and antimicrobial susceptibility testing
Pus samples were inoculated in a 5% defibrillated sheep blood medium, and β-hemolytic colonies were selected for bacitracin detection. Positive strains were identified as GAS by Lancefield group-specific antiserum.
We tested the susceptibility of the 14 strains to eight antimicrobial agents (penicillin, azithromycin, erythromycin, clarithromycin, clindamycin, tetracycline, levofloxacin, and chloramphenicol; Oxoid Limited). Minimum inhibitory concentration (MIC) values were determined according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI; 2016–2018) by using the broth dilution method. Quality control was performed using Streptococcus pneumoniae ATCC 49619, which was provided by the Clinical Test Center of the Ministry of Health and maintained by the Microbiology Laboratory of Shenzhen Children's Hospital.
DNA extraction and emm sequence typing
Genomic DNA was obtained from freshly grown GAS culture using a Chelex-based DNA extracting kit for genetic analysis. Following a previously reported protocol (https://www2.cdc.gov/vaccines/biotech/strepblast.asp), emm sequence types were determined. The DNA extraction kit, PCR reagents, and primers were all obtained from Shanghai SBS Genetech Co., Ltd. (China). Amplicons were sequenced by Guangzhou BGI Genomics Co. Ltd. The emm sequence type was determined based on the sequence identity (>95%) of the first 180 bp of the emm gene between the tested sequence and the reference emm gene.
Statement of ethics
This study was approved by the Research Ethics Committee of the Shenzhen Children's Hospital (No. 202107802). Informed consent was obtained from patients or their guardians before sample collection.
Diagnostic assessment
Patients' baseline characteristics
A total of 14 hospitalized patients with culture-confirmed abscesses were included. There were 10 male patients (71.43%) and four female patients (28.57%). The age of the patients ranged from 3 months to 10.8 years, and the median age was 1.8 years. No patients had any underlying condition.
Clinical characteristics
Among the 14 patients, the disease course was 2–18 days, with a median length of 7 days. All 14 patients had inflammatory manifestations, such as localized skin redness, swelling, localized pain, and localized increase in skin temperature. Five patients had fever, while nine patients had no fever. The most common sites of infection were the lower limbs, including the calves in two patients, the knees in two patients, the thighs, hips, feet, and ankles in one patient, the mouth, neck, armpits, hand, elbow plus hand, and the upper limbs in one patient. For all 14 patients, we performed puncture and drainage of abscesses and successfully obtained pus after puncture. After the bacterial culture, all 14 pus samples were confirmed positive for iGAS infection. The details of the specific clinical presentation of the patients are provided in Table 1.
Laboratory results
A blood routine initial leukocyte count was quite variable. Leukocytosis was presented in 12 (85.71%) patients (12.35–46.82 × 10^9^/L). C reactive protein (CRP) levels were detected in 13 patients, and seven patients (53.8%, 7/13) had higher levels of CRP (15.3–126 mg/L) than the normal value (10 mg/L). The levels of erythrocyte sedimentation rate (ESR) were detected in 11 patients, and 10 patients (90.9%) had higher ESR levels (25–89 mm/h) than the normal value (15 mm/h). Procalcitonin levels in sera were detected in eight patients, and four patients (50.5%) had higher procalcitonin levels (0.71–0.92 ng/mL) than the normal value (0.5 mg/L). Local ultrasound showed local soft tissue inflammatory thickening/mass with liquefaction. All 14 patients underwent abscess incision and drainage, and the puncture fluid was sent for microbial culture, which indicated the growth of GAS. One patient had a complication of varicella. In this patient, the herpes fluid culture also showed GAS and the throat swab for the GAS antigen was positive. Based on the emm typing, the 14 patients showed three strains of emm1 and its subtypes, one strain of emm2.0 type, one strain of emm4.0 type, two strains of emm6.4 type, five strains of emm12 type and its subtypes, one strain of emm28.0 type, and one strain of emm75.0 type. The emm typing is summarized in Table 1. All tested strains were phenotypically sensitive to penicillin, levofloxacin, and chloramphenicol. The resistance rate to azithromycin, erythromycin, clarithromycin, clindamycin, and tetracycline was 78.6%. The results of the susceptibility of S. pyogenes strains to antimicrobial agents are shown in Table 2.
Details on the therapeutic intervention
The medium hospital stay was 7 days (2–18 days). The details of the therapy for the 14 patients are summarized in Table 1. All 14 patients were treated with intravenous antibiotics. A total of eight patients were treated with amoxicillin sodium sulbactam sodium, two patients with cefoperazone sodium sulbactam sodium, two patients with cefuroxime, one patient with vancomycin + cefoperazone sodium sulbactam sodium, and one patient with ceftriaxone/cefuroxime + vancomycin.
Follow-up and outcomes
The follow-up for all 14 patients was conducted by telephone. No patients experienced sequelae, such as nephritis, rheumatic fever, and rheumatic heart disease.
Discussion
GAS can cause a broad spectrum of infections, ranging from minor illnesses, such as pharyngitis and superficial skin infections, to severe and invasive diseases. iGAS infection is a life-threatening condition, with high case fatality and high morbidity rates (7). Surveillance is essential to accurately determine the real burden of this disease in children. According to the Active Bacterial Core surveillance reports of the National Center for Disease Control (CDC), overall iGAS incidence increased every year from 2012 to 2019 (7). iGAS infections are defined as infectious diseases associated with iGAS isolated from a sterile site in the body, such as sepsis, arthritis, pleurisy, and abscesses. All 14 iGAS isolates in this case series were isolated from sterile sites (pus from soft tissue infections), and therefore, all 14 patients were considered to have iGAS infections (7). There is a professional surveillance network for iGAS diseases in North America, while the National Center for Disease Control (CDC) in China only monitors scarlet fever caused by iGAS infection as part of its real-time surveillance of infectious diseases. According to a report from Canada, the incidence of iGAS diseases among aborigines in Alberta increased from 10/100,000 in 2003 to 52.2/100,000 in 2017 (8). In China, GAS-related invasive diseases may be underestimated because they are not routinely monitored.
This case report included more male patients (n = 10) than female patients (n = 4), which may be related to the greater activity level of boys vs. girls of the same age and thus a greater risk of local injury in boys. In terms of age, half of the patients were in the early childhood period of 1–3 years. During this toddler period, children typically lack a good sense of self-protection and are easily injured, which can lead to localized infections.
Emm typing is the most commonly used molecular typing method for the study of GAS. In the present case series, emm1 (and its subtypes) and emm12 (and its subtypes) accounted for the highest proportion, which is consistent with other reports in China from the past 2 years (9, 10). Other types, such as emm2.0, emm4.0, emm6.4, emm28.0, and emm75.0, were detected at lower rates in this case series, indicating that all types of emm GAS may cause invasive infections, including the formation of soft tissue abscesses. For example, a study in Finland (11) showed that the emm GAS type that causes puerperal infections in young women is emm28. An outbreak of invasive GAS disease in New Zealand was confirmed to be caused by an emm81 clone (12). A patient with a non-necrotizing soft tissue infection and streptococcal toxic shock syndrome (STSS) caused by a novel emm subtype (emm76.10) of GAS was reported (13). Other studies found that emm1, emm28, emm42.1, emm55, and emm25 are more likely to cause invasive infections than other emm types (14, 15). Furthermore, the most common emm type of GAS varies across different age groups and regions (16–18).
With regard to the pathogens that can easily cause abscesses, the pathogens most commonly reported as the cause of orbital and periorbital abscesses are Pseudomonas aeruginosa, Streptococcus constellation, Staphylococcus epidermidis, Staphylococcus aureus, and others (19). However, the 14 children with abscesses in this case series were all infected with iGAS, which has been relatively rarely reported in China.
With regard to the site of infection, among the 14 patients in this series, eight had infections in the lower extremities, distributed among the thighs, knees, legs, and feet. Only three patients had infections in the upper limbs, and the other infection sites were the neck, armpits, and oral cavity. From these cases, it can be seen that abscess formation upon iGAS infection is most likely to occur in the limbs. The reasons behind the limbs being prone to abscesses have been analyzed (20). The hands are the most exposed parts of the body and thus the most vulnerable to injury, allowing them to be easily infected with bacteria. In patients with infections, pus can spread to the deep tissues, permitting abscess formation, which can lead to pain, fever, and other systemic symptoms, including even sepsis. Necrotizing infection is not only a threat to the limbs but also to life. As a result, a hand injury that initially appears to be “trivial” should never be ignored as it can develop into a deep infection that requires drainage, wound debridement, and intravenous antibiotic treatment as soon as it is found. Delayed diagnosis and improper early treatment can quickly lead to the formation of abscesses, the destruction of the normal anatomical structure, and irreparable functional degradation. In addition to abscess formation in the limbs, various reports have shown that iGAS infection can cause iliolumbar abscess (21), abdominal wall abscess (22), lumbar epidural abscess (23), nasal septum abscess (24) spinal epidural abscess (25), brain abscess (26), and so on. Accordingly, abscesses caused by iGAS infections can occur at various sites. Thus, even if the disease is only a superficial soft tissue infection, it should not be ignored and should be treated immediately to prevent aggravation.
Based on the laboratory examination results, leukocytosis was common in the present case series. An increased white blood cell (WBC) count occurred in 12 of the 14 patients, and in nine of the 12 patients, the WBC count was >20 × 10^9^/L. In almost all patients, the WBC count was dominated by an increase in neutrophils, and the proportion of neutrophils was more than 60% in nine patients (9/13). In addition, the level of CRP was generally increased in seven of the 13 patients, among which six patients had CRP levels above 20 mg/L. An increased ESR level was detected in 12 of the 13 patients. However, the procalcitonin level was not increased in the majority of patients, with only four patients (4/14) showing a slight increase (0.71–0.92 ng/mL). The children who were hospitalized for more than 8 days had the following characteristics: a WBC count >20 × 10^9^/L and/or a very high CRP level, exceeding 20 mg/L, as well as an increased ESR level by varying degrees. Therefore, in children with abscesses following soft tissue infections, total leukocyte counts, neutrophil ratios, CRP levels, and blood sedimentation rates can be used as tests that, in combination with essentially normal or slightly elevated calcitoninogen levels, predict local rather than systemic infection. This is consistent with previous findings where it was observed that CRP is more sensitive than procalcitonin in differentiating local bacterial infections (27). Such results need to be validated in future studies.
For the treatment of abscesses, timely determination of the cause of the disease and drainage are necessary. It is crucial to send the drainage fluid for immediate microbiological culture. Antibiotics can be used empirically before the results of the bacterial culture. Then, when the results of the bacterial culture are obtained, the antibiotics can be adjusted according to the results of the antibiotic sensitivity test. According to the Clinical and Laboratory Standards Institute (CLSI) 2020 standard, penicillin and ampicillin are always the first choice for the treatment of hemolytic streptococcal infections. Non-sensitive isolates are extremely rare among any β-hemolytic streptococcus, and GAS has not been reported among non-sensitive isolates. All strains analyzed in this study were susceptible to penicillin, levofloxacin, and chloramphenicol. Therefore, penicillin can remain the first-line antibiotic for treating GAS infections in pediatric patients in China. Among the 14 patients, 12 patients were treated with β-lactam antibiotics and two patients were treated with vancomycin. Penicillin and other β-lactam antibiotics are the first choice for the treatment of iGAS infections. Previous studies have mentioned the use of intravenous immunoglobulins (IVIGs) and clindamycin in the treatment of iGAS infections, but these drugs were not used in this series, and despite that, all the patients recovered well (7). Penicillin tolerance has been involved in treatment failures in patients with GAS infections, and some studies have found an association with penicillin tolerance (28, 29).
Conclusion
GAS is one of the most common pathogens causing abscesses. The WBC count, CRP level, and ESR of patients with this type of abscess usually increase to varying degrees, whereas the procalcitonin level likely remains in the normal range or increases only slightly. After the diagnosis of an abscess is confirmed, the abscess should be drained urgently and the drainage fluid should be sent for microbial culture immediately. β-lactam antimicrobials are the therapeutic agents of choice for the treatment of iGAS infections, and a replacement with vancomycin may be required as an alternative for some patients who do not respond well to treatment.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
This study was approved by the Research Ethics Committee of the Shenzhen Children's Hospital (No. 202107802). Informed consent was obtained from patients or their guardians before sample collection. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
DG: Formal analysis, Methodology, Data curation, Writing – original draft. SZ: Data curation, Formal analysis, Methodology, Writing – original draft, Conceptualization. QL: Data curation, Formal analysis, Writing – review & editing. YC: Writing – review & editing, Resources. QM: Resources, Writing – review & editing. LS: Resources, Writing – review & editing. YZ: Conceptualization, Funding acquisition, Investigation, Supervision, Writing – review & editing. WW: Funding acquisition, Supervision, Writing – review & editing. DY: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Chaudhary P Kumar R Sagar V Sarkar S Singh R Ghosh S. Assessment of Cpa, Scl 1 and Scl 2 in clinical group A Streptococcus isolates and patients from north India: an evaluation of the host pathogen interaction. Res Microbiol. (2018) 169:11–9. 10.1016/j.resmic.2017.09.00228974446 · doi ↗ · pubmed ↗
- 2Yu D Liang Y Lu Q Zheng Y Gao GF Yang Y. Thoughts on group A Streptococci. Lancet Microbe. (2023) 4:e 484–5. 10.1016/S 2666-5247(23)00138-637209704 · doi ↗ · pubmed ↗
- 3Yu D Zheng Y Gao GF Yang Y. Additional thoughts on group A Streptococci. Lancet Microbe. (2024) 99:5. 10.1016/S 2666-5247(24)00099-538723643 · doi ↗ · pubmed ↗
- 4Hua C Yu H Xu H Yang L Lin A Lyu Q. A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010–2017. BMC Pediatr. (2019) 19:181. 10.1186/s 12887-019-1536-131167650 PMC 6549372 · doi ↗ · pubmed ↗
- 5Lamagni T Mc Gregor C Guy RL Whitworth J Efstratiou A. Seizing opportunities for prevention of group A Streptococcal infection. Lancet Microbe. (2024) 404:4. 10.1016/S 2666-5247(23)00404-438278164 · doi ↗ · pubmed ↗
- 6Vieira A Wan Y Ryan Y Li HK Guy RL Papangeli M. Rapid expansion and international spread of M 1(UK) in the post-pandemic UK upsurge of Streptococcus pyogenes. Nat Commun. (2024) 15:3916. 10.1038/s 41467-024-47929-738729927 PMC 11087535 · doi ↗ · pubmed ↗
- 7Mariani F Gentili C Pulcinelli V Martino L Valentini P Buonsenso D. State of the art of invasive group A Streptococcus infection in children: a scoping review of the literature with a focus on predictors of invasive infection. Children. (2023) 10:1–14. 10.3390/children 1009147237761433 PMC 10528266 · doi ↗ · pubmed ↗
- 8Tyrrell G Bell C Bill L Fathima S. Increasing incidence of invasive group A Streptococcus disease in first nations po pulation, Alberta, Canada, 2003–2017. Emerg Infect Dis. (2021) 27:443–51. 10.3201/eid 2702.20194533496247 PMC 7853581 · doi ↗ · pubmed ↗
